Similar articles for PMID: 30097503

Year	Number of Results
2009	1
2011	1
2012	1
2013	1
2014	1
2015	9
2016	16
2017	14
2018	18
2019	16
2020	15
2021	17
2022	9
2023	6
2024	0

1

Monosodium Glutamate Reduces ⁶⁸Ga-PSMA-11 Uptake in Salivary Glands and Kidneys in a Preclinical Prostate Cancer Model.

Rousseau E, Lau J, Kuo HT, Zhang Z, Merkens H, Hundal-Jabal N, Colpo N, Lin KS, Bénard F. Rousseau E, et al. J Nucl Med. 2018 Dec;59(12):1865-1868. doi: 10.2967/jnumed.118.215350. Epub 2018 Aug 10. J Nucl Med. 2018. PMID: 30097503 Free PMC article.

2

The Theranostic PSMA Ligand PSMA-617 in the Diagnosis of Prostate Cancer by PET/CT: Biodistribution in Humans, Radiation Dosimetry, and First Evaluation of Tumor Lesions.

Afshar-Oromieh A, Hetzheim H, Kratochwil C, Benesova M, Eder M, Neels OC, Eisenhut M, Kübler W, Holland-Letz T, Giesel FL, Mier W, Kopka K, Haberkorn U. Afshar-Oromieh A, et al. J Nucl Med. 2015 Nov;56(11):1697-705. doi: 10.2967/jnumed.115.161299. Epub 2015 Aug 20. J Nucl Med. 2015. PMID: 26294298 Free article.

3

The Effects of Monosodium Glutamate on PSMA Radiotracer Uptake in Men with Recurrent Prostate Cancer: A Prospective, Randomized, Double-Blind, Placebo-Controlled Intraindividual Imaging Study.

Harsini S, Saprunoff H, Alden T, Mohammadi B, Wilson D, Bénard F. Harsini S, et al. J Nucl Med. 2021 Jan;62(1):81-87. doi: 10.2967/jnumed.120.246983. Epub 2020 May 8. J Nucl Med. 2021. PMID: 32385167 Free article. Clinical Trial.

4

What a difference a methylene makes: replacing Glu with Asp or Aad in the Lys-urea-Glu pharmacophore of PSMA-targeting radioligands to reduce kidney and salivary gland uptake.

Kuo HT, Lin KS, Zhang Z, Zhang C, Merkens H, Tan R, Roxin A, Uribe CF, Bénard F. Kuo HT, et al. Theranostics. 2022 Aug 21;12(14):6179-6188. doi: 10.7150/thno.76571. eCollection 2022. Theranostics. 2022. PMID: 36168623 Free PMC article.

5

Biodistribution and radiation dosimetry for a probe targeting prostate-specific membrane antigen for imaging and therapy.

Herrmann K, Bluemel C, Weineisen M, Schottelius M, Wester HJ, Czernin J, Eberlein U, Beykan S, Lapa C, Riedmiller H, Krebs M, Kropf S, Schirbel A, Buck AK, Lassmann M. Herrmann K, et al. J Nucl Med. 2015 Jun;56(6):855-61. doi: 10.2967/jnumed.115.156133. Epub 2015 Apr 16. J Nucl Med. 2015. PMID: 25883128 Free PMC article.

6

⁶⁸Ga-PSMA-HBED-CC PET/CT imaging for adenoid cystic carcinoma and salivary duct carcinoma: a phase 2 imaging study.

van Boxtel W, Lütje S, van Engen-van Grunsven ICH, Verhaegh GW, Schalken JA, Jonker MA, Nagarajah J, Gotthardt M, van Herpen CML. van Boxtel W, et al. Theranostics. 2020 Jan 12;10(5):2273-2283. doi: 10.7150/thno.38501. eCollection 2020. Theranostics. 2020. PMID: 32089741 Free PMC article. Clinical Trial.

7

Effects of Linker Modification on Tumor-to-Kidney Contrast of ⁶⁸Ga-Labeled PSMA-Targeted Imaging Probes.

Kuo HT, Pan J, Zhang Z, Lau J, Merkens H, Zhang C, Colpo N, Lin KS, Bénard F. Kuo HT, et al. Mol Pharm. 2018 Aug 6;15(8):3502-3511. doi: 10.1021/acs.molpharmaceut.8b00499. Epub 2018 Jul 3. Mol Pharm. 2018. PMID: 29920108

8

Normal distribution pattern and physiological variants of 68Ga-PSMA-11 PET/CT imaging.

Demirci E, Sahin OE, Ocak M, Akovali B, Nematyazar J, Kabasakal L. Demirci E, et al. Nucl Med Commun. 2016 Nov;37(11):1169-79. doi: 10.1097/MNM.0000000000000566. Nucl Med Commun. 2016. PMID: 27333090

9

[⁶⁸Ga]Ga-P16-093 as a PSMA-Targeted PET Radiopharmaceutical for Detection of Cancer: Initial Evaluation and Comparison with [⁶⁸Ga]Ga-PSMA-11 in Prostate Cancer Patients Presenting with Biochemical Recurrence.

Green MA, Hutchins GD, Bahler CD, Tann M, Mathias CJ, Territo W, Sims J, Polson H, Alexoff D, Eckelman WC, Kung HF, Fletcher JW. Green MA, et al. Mol Imaging Biol. 2020 Jun;22(3):752-763. doi: 10.1007/s11307-019-01421-7. Mol Imaging Biol. 2020. PMID: 31429050 Free PMC article.

10

PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions.

Afshar-Oromieh A, Malcher A, Eder M, Eisenhut M, Linhart HG, Hadaschik BA, Holland-Letz T, Giesel FL, Kratochwil C, Haufe S, Haberkorn U, Zechmann CM. Afshar-Oromieh A, et al. Eur J Nucl Med Mol Imaging. 2013 Apr;40(4):486-95. doi: 10.1007/s00259-012-2298-2. Epub 2012 Nov 24. Eur J Nucl Med Mol Imaging. 2013. PMID: 23179945

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year